Vaccinating the Immunocompromised against Respiratory Viruses

Immunocompromised patients are at high risk for severe outcomes from respiratory viral infections. In response, the Infectious Diseases Society of America (IDSA) has released vaccine recommendations for this population based on expert consensus and a previously published systematic review of available safety and efficacy data. The recommendations apply to patients with hematologic malignancy, primary immunodeficiency, or advanced HIV infection (CD4-cell count <200/mm³); recipients of solid organ or hematopoietic cell transplants; and patients receiving biologics or immun…